5 Things To Look Out For In Cell Therapy Supply Chain

By Travis Ott, Senior Manager of Supply Chain and Customer Support, Invetech

What current global supply chain issues translate to for cell therapy developers who rely on supply chain to run their clinical trials or to initiate commercialization efforts? In short, (even) longer lead times globally. Developers are not only experiencing primary supplier issues, but secondary supplier issues as Tier II suppliers are affected as well.

While there is no silver bullet to fix the ongoing global challenges, taking a proactive approach to your supply chain management can help alleviate some of the pressure.

Here are the top five things that cell therapy supply chain professionals should focus on in 2022.